Literature DB >> 21288835

Pandemic H1N1 influenza infection and vascular thrombosis.

Paul E Bunce1, Sasha M High, Maral Nadjafi, Katherine Stanley, W Conrad Liles, Michael D Christian.   

Abstract

During the summer and fall of 2009, significant thrombotic events were observed in patients infected with the pandemic H1N1 influenza A virus. In a retrospective chart review of 119 individuals admitted to the hospital with H1N1 virus infection, 7 patients (5.9%) were found to have experienced thrombotic vascular events.

Entities:  

Mesh：

Year:  2011        PMID： 21288835     DOI： 10.1093/cid/ciq125

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  60 in total

1.  In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1).

Authors:  Matthew T Rondina; BreAnna Brewster; Colin K Grissom; Guy A Zimmerman; Diana H Kastendieck; Estelle S Harris; Andrew S Weyrich
Journal:  Chest       Date:  2012-03-01       Impact factor: 9.410

2.  Neutrophil extracellular traps in COVID-19.

Authors:  Yu Zuo; Srilakshmi Yalavarthi; Hui Shi; Kelsey Gockman; Melanie Zuo; Jacqueline A Madison; Christopher Blair; Andrew Weber; Betsy J Barnes; Mikala Egeblad; Robert J Woods; Yogendra Kanthi; Jason S Knight
Journal:  JCI Insight       Date:  2020-06-04

3.  Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity.

Authors:  A J Gerard Jansen; Thom Spaan; Hui Zhi Low; Daniele Di Iorio; Judith van den Brand; Malte Tieke; Arjan Barendrecht; Kerstin Rohn; Geert van Amerongen; Koert Stittelaar; Wolfgang Baumgärtner; Albert Osterhaus; Thijs Kuiken; Geert-Jan Boons; Jurriaan Huskens; Marianne Boes; Coen Maas; Erhard van der Vries
Journal:  Blood Adv       Date:  2020-07-14

4.  Microvesicle Tissue Factor Activity and Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection.

Authors:  Matthew T Rondina; Kohei Tatsumi; Julie A Bastarache; Nigel Mackman
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

Review 5.  Emerging roles for platelets as immune and inflammatory cells.

Authors:  Craig N Morrell; Angela A Aggrey; Lesley M Chapman; Kristina L Modjeski
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

6.  Thrombotic risk in COVID-19: a case series and case-control study.

Authors:  Simon M Stoneham; Kate M Milne; Elisabeth Nuttall; Georgina H Frew; Beattie Rh Sturrock; Helena Sivaloganathan; Eleni E Ladikou; Stephen Drage; Barbara Phillips; Timothy Jt Chevassut; Alice C Eziefula
Journal:  Clin Med (Lond)       Date:  2020-05-18       Impact factor: 2.659

7.  Viral infection-induced thrombosis, novel coronavirus.

Authors:  Lemuel Pran; Shanta Baijoo; Hani Slim
Journal:  J Vasc Surg       Date:  2020-05-11       Impact factor: 4.268

Review 8.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 9.  Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis.

Authors:  Milka Koupenova; Lauren Clancy; Heather A Corkrey; Jane E Freedman
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

10.  Complications in COVID-19 patients: Characteristics of pulmonary embolism.

Authors:  Riccardo Cau; Alberto Pacielli; Homayounieh Fatemeh; Paolo Vaudano; Chiara Arru; Paola Crivelli; Giuseppe Stranieri; Jasjit S Suri; Lorenzo Mannelli; Maurizio Conti; Abdelkader Mahammedi; Mannudeep Kalra; Luca Saba
Journal:  Clin Imaging       Date:  2021-05-18       Impact factor: 1.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.